Walleye Trading’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.33M Sell
10,400
-13,800
-57% -$3.44M ﹤0.01% 1612
2025
Q4
$5.83M Buy
24,200
+700
+3% +$179K 0.01% 1201
2025
Q3
$6.43M Sell
23,500
-11,900
-34% -$3.25M 0.01% 1119
2025
Q2
$9.13M Buy
35,400
+14,800
+72% +$3.53M 0.02% 868
2025
Q1
$4.61M Buy
20,600
+12,800
+164% +$2.99M 0.01% 1148
2024
Q4
$1.78M Sell
7,800
-63,700
-89% -$15.3M ﹤0.01% 1762
2024
Q3
$17.5M Buy
71,500
+21,800
+44% +$4.87M 0.04% 515
2024
Q2
$9.51M Buy
49,700
+23,000
+86% +$4.67M 0.02% 705
2024
Q1
$5.29M Buy
26,700
+12,900
+93% +$2.36M 0.01% 1086
2023
Q4
$2.37M Buy
13,800
+10,900
+376% +$1.67M 0.01% 1797
2023
Q3
$429K Sell
2,900
-3,300
-53% -$597K ﹤0.01% 3074
2023
Q2
$1.35M Buy
6,200
+900
+17% +$201K ﹤0.01% 1932
2023
Q1
$1.16M Buy
+5,300
New +$1.15M ﹤0.01% 2083
2022
Q4
Sell
-900
Closed -$196K 5344
2022
Q3
$196K Sell
900
-13,300
-94% -$3.03M ﹤0.01% 3688
2022
Q2
$2.98M Buy
+14,200
New +$3.02M 0.01% 1365
2022
Q1
Sell
-100
Closed -$26K 5839
2021
Q4
$26K Sell
100
-1,200
-92% -$311K ﹤0.01% 4854
2021
Q3
$343K Buy
+1,300
New +$355K ﹤0.01% 3329
2021
Q2
Sell
-4,100
Closed -$795K 5485
2021
Q1
$795K Sell
4,100
-6,300
-61% -$1.26M ﹤0.01% 2147
2020
Q4
$2.21M Sell
10,400
-200
-2% -$39.9K 0.01% 1318
2020
Q3
$1.82M Buy
10,600
+5,500
+108% +$1.02M 0.01% 1195
2020
Q2
$979K Buy
5,100
+1,300
+34% +$213K 0.01% 1683
2020
Q1
$560K Buy
3,800
+100
+3% +$15.9K ﹤0.01% 1789
2019
Q4
$573K Sell
3,700
-4,700
-56% -$677K ﹤0.01% 2293
2019
Q3
$1.14M Sell
8,400
-21,400
-72% -$2.8M 0.01% 1500
2019
Q2
$3.64M Buy
29,800
+22,300
+297% +$2.47M 0.03% 643
2019
Q1
$780K Buy
7,500
+7,200
+2,400% +$743K 0.01% 1890
2018
Q4
$34K Sell
300
-21,200
-99% -$2.27M ﹤0.01% 4243
2018
Q3
$2.48M Buy
21,500
+12,500
+139% +$1.37M 0.01% 1128
2018
Q2
$932K Buy
+9,000
New +$911K 0.01% 2183
2017
Q4
Sell
-1,000
Closed -$77 4593
2017
Q3
$77 Sell
1,000
-10,700
-91% -$819K ﹤0.01% 3697
2017
Q2
$911 Sell
11,700
-22,800
-66% -$1.63M 0.01% 1858
2017
Q1
$2.48K Buy
34,500
+4,500
+15% +$311K 0.02% 927
2016
Q4
$1.86M Buy
30,000
+10,300
+52% +$631K 0.01% 1018
2016
Q3
$1.28M Buy
19,700
+18,700
+1,870% +$1.24M 0.01% 1337
2016
Q2
$63K Sell
1,000
-1,100
-52% -$64.8K ﹤0.01% 3834
2016
Q1
$122K Buy
+2,100
New +$119K ﹤0.01% 3183
2014
Q3
Sell
-100
Closed -$5 4319
2014
Q2
$5 Buy
+100
New +$4.96K ﹤0.01% 3507
2013
Q4
Sell
-1,700
Closed -$89K 3775
2013
Q3
$89K Sell
1,700
-400
-19% -$19.4K ﹤0.01% 2030
2013
Q2
$95K Buy
+2,100
New +$99.6K ﹤0.01% 2033

Other funds holding RMD

Walleye Trading's RMD Position: Q1 2026 in Review

Walleye Trading reduced its ResMed (RMD) stake by 66% in Q1 2026, selling an estimated $654K and leaving 1,335 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #2883.

Walleye Trading first reported a position in RMD in Q2 2013 and has held it in 29 quarters since. The position peaked at $2.95M in Q1 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Walleye Trading held 1,335 shares of ResMed worth $300K as of Q1 2026.
  • Walleye Trading sold 2,623 ResMed shares in Q1 2026, an estimated $654K.
  • ResMed made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2883 holding.
  • Walleye Trading first reported a position in ResMed in Q2 2013 and has held it in 29 quarters since.
  • Walleye Trading's ResMed position peaked at $2.95M in Q1 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.